Nimish P Shah's Net Worth
$687 Million
Who is Nimish P Shah?
Nimish P Shah has an estimated net worth of $687 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., Instil Bio, Inc., CONSTELLATION PHARMACEUTICALS INC, Apogee Therapeutics, Inc., Shockwave Medical, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and ARCA biopharma, Inc..
SEC CIK
Nimish P Shah's CIK is 0001698082
Past Insider Trading and Trends
2022 was Nimish P Shah's most active year for acquiring shares with 46 total transactions. Nimish P Shah's most active month to acquire stocks was the month of May. 2021 was Nimish P Shah's most active year for disposing of shares, totalling 6 transactions. Nimish P Shah's most active month to dispose stocks was the month of February. 2023 saw Nimish P Shah paying a total of $29,750,000.00 for 1,797,758 shares, this is the most they've acquired in one year. In 2019 Nimish P Shah cashed out on 1,593,847 shares for a total of $14,899,957.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.06% | 400K |
$34.50 | $13,800,000.00 | 4.02M |
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Shockwave Medical, Inc. (SWAV) Snapshot price: $235.215
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.12M |
—
|
—
| 2.12M |
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.525
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| +1.82% | 86.05K |
$14.62 | $1,257,828.78 | 4.82M |
Feb 6 - Feb 8
| |||
Form 4
| +1.89% | 88.1K |
$14.47 | $1,274,792.53 | 4.74M |
Jan 30
| |||
Form 4
| +2.01% | 91.8K |
$14.05 | $1,289,802.42 | 4.65M |
Jan 25 - Jan 29
| |||
Form 4
| +2.22% | 99.13K |
$12.53 | $1,241,684.52 | 4.56M |
Jan 22 - Jan 24
| |||
Form 4
| +3.33% | 143.6K |
$12.55 | $1,801,601.80 | 4.46M |
Jan 17 - Jan 19
| |||
Form 4
| +0.61% | 26.25K |
$12.72 | $333,779.23 | 4.32M |
Jan 11 - Jan 16
| |||
Form 4
| +3.32% | 137.7K |
$12.54 | $1,726,456.92 | 4.29M |
Jan 8 - Jan 10
| |||
Form 4
| +1.45% | 59.37K |
$12.14 | $720,543.04 | 4.15M |
Jan 3 - Jan 4
| |||
Form 4
| +14.52% | 519.02K |
$12.46 | $6,465,649.95 | 4.09M |
Dec 27 - Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -24.46% | -500.00K |
$28.75 | -$14,375,000.00 | 1.54M |
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Altimmune, Inc. (ALT) Snapshot price: $10.445
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.22% | -1.00M |
—
|
—
| 3.5M |
Feb 25
| |||
Form 4
| +50.00% | 1.5M |
$7.54 | $11,310,000.00 | 4.5M |
Jun 15
| |||
Form 4
| +76.85% | 1.3M |
$8.74 | $11,395,493.13 | 3M |
May 26 - May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Unum Therapeutics Inc. (COGT) Snapshot price: $5.865
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.55% | 451K |
$2.52 | $1,137,120.00 | 4.36M |
Aug 14 - Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |